IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

October 6-8, 2020

Cambridge Health Institute’s (CHI) 5th Annual Oncolytic Virus Immunotherapy Summit

Stephen J. Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer. Presentation: “Engineering the Immune Response to Blaze a Trail for Oncolytic Immunotherapy.” Panel Discussion: Current Challenges in Oncolytic Virotherapy

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com